Comerica Bank
ATRS

Comerica Bank’s Antares Pharma, Inc. ATRS Stock Holding History

Comerica Bank’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,507
Closed -$37K – 2240
2014
Q1 		$37K Buy
10,507
+215
+2% +$954 ﹤0.01% 2266
2013
Q4 		$46K Hold
10,292
– – ﹤0.01% 2236
2013
Q3 		$42K Buy
10,292
+149
+1% +$651 ﹤0.01% 2570
2013
Q2 		$42K Buy
+10,143
New +$39.2K ﹤0.01% 2251

Other funds holding ATRS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Comerica Bank's ATRS Position: Q2 2014 in Review

Comerica Bank sold out of Antares Pharma, Inc. (ATRS) in Q2 2014, closing a stake of 10,507 shares — an estimated $37K sold.

Comerica Bank first reported a position in ATRS in Q2 2013 and held it in 4 quarters. The position peaked at $46K in Q4 2013. 85 funds tracked by Wall St. Rank hold ATRS as of Q2 2014.

  • Comerica Bank reported no remaining Antares Pharma, Inc. position as of Q2 2014 after selling out during the quarter.
  • Comerica Bank sold 10,507 Antares Pharma, Inc. shares in Q2 2014, an estimated $37K.
  • Comerica Bank first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 4 quarters.
  • Comerica Bank's Antares Pharma, Inc. position peaked at $46K in Q4 2013.
  • 85 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2014.

Based on Comerica Bank's 13F filing for Q2 2014, filed 12 Aug 2014.